Incretin-based Therapy in Late Preclinical Type 1 Diabetes

NCT02898506 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

13

Enrollment

OTHER

Sponsor class

Conditions

Type 1 Diabetes

Interventions

DRUG: Victoza®
DRUG: Placebo

Sponsor

University of Oulu

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]